Achieve Life Sciences Inc. Common Shares (ACHV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Achieve Life Sciences Inc. Common Shares, updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$6.85
−1.15% today
Market cap
$713M
Overall quality
50/100
Kronos AI 30-day
−10.8%
2 of 8 simulated paths end higher
Achieve Life Sciences Inc. Common Shares (ACHV) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $713M. It trades at $6.85, down 1.15% today. Its overall quality score is 50 out of 100, ranked against the whole US market. 6 analysts' average target of $13.83 implies +101.9% from today's price. Kronos AI's 30-day forecast is −10.8% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $13.83 |
| Low – high | $10.00 – $18.00 |
| Analysts | 6 |
| Upside to average | +101.9% |
Kronos AI 30-day forecast
| Expected close | $6.18 (−10.8%) |
| Likely range | −19.6% … +4.4% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 77 |
| Growth | 38 |
| Overall | 50 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.